Qube Research & Technologies (QRT)
ELTX icon

Qube Research & Technologies (QRT)’s Elicio Therapeutics ELTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,482
Closed -$133K – 3626
2026
Q1 		$133K Sell
12,482
-7,734
-38% -$74.7K ﹤0.01% 3023
2025
Q4 		$161K Buy
+20,216
New +$183K ﹤0.01% 3098
2022
Q4 		– Sell
-1,433
Closed -$13K – 2592
2022
Q3 		$13K Sell
1,433
-129
-8% -$1.35K ﹤0.01% 2338
2022
Q2 		$18K Buy
+1,562
New +$24.9K ﹤0.01% 2275
2022
Q1 		– Sell
-1,141
Closed -$33K – 2587
2021
Q4 		$33K Buy
+1,141
New +$57.7K ﹤0.01% 2316

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ELTX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Elicio Therapeutics (ELTX) in Q2 2026, closing a stake of 12,482 shares — an estimated $133K sold.

Qube Research & Technologies (QRT) first reported a position in ELTX in Q4 2021 and held it in 5 quarters. The position peaked at $161K in Q4 2025. 48 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Elicio Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 12,482 Elicio Therapeutics shares in Q2 2026, an estimated $133K.
  • Qube Research & Technologies (QRT) first reported a position in Elicio Therapeutics in Q4 2021 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Elicio Therapeutics position peaked at $161K in Q4 2025.
  • 48 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.